- Home
- NTIC vs INMB Comparison
NTIC vs INMB Comparison
Compare NTIC & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- INMB
- Stock Information
- Founded
- NTIC 1970
- INMB 2015
- Country
- NTIC United States
- INMB United States
- Employees
- NTIC N/A
- INMB N/A
- Industry
- NTIC Industrial Specialties
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- INMB Health Care
- Exchange
- NTIC Nasdaq
- INMB Nasdaq
- Market Cap
- NTIC 121.6M
- INMB 103.1M
- IPO Year
- NTIC N/A
- INMB 2019
- Fundamental
- Price
- NTIC $12.90
- INMB $6.45
- Analyst Decision
- NTIC Buy
- INMB Strong Buy
- Analyst Count
- NTIC 1
- INMB 2
- Target Price
- NTIC $20.00
- INMB $21.00
- AVG Volume (30 Days)
- NTIC 26.0K
- INMB 377.7K
- Earning Date
- NTIC 01-08-2025
- INMB 10-31-2024
- Dividend Yield
- NTIC 2.17%
- INMB N/A
- EPS Growth
- NTIC 52.91
- INMB N/A
- EPS
- NTIC 0.52
- INMB N/A
- Revenue
- NTIC $86,216,235.00
- INMB $42,000.00
- Revenue This Year
- NTIC $11.04
- INMB N/A
- Revenue Next Year
- NTIC $8.10
- INMB N/A
- P/E Ratio
- NTIC $24.81
- INMB N/A
- Revenue Growth
- NTIC 7.59
- INMB N/A
- 52 Week Low
- NTIC $11.70
- INMB $4.32
- 52 Week High
- NTIC $19.63
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- NTIC 43.11
- INMB 63.48
- Support Level
- NTIC $12.70
- INMB $5.82
- Resistance Level
- NTIC $13.41
- INMB $6.83
- Average True Range (ATR)
- NTIC 0.62
- INMB 0.55
- MACD
- NTIC -0.05
- INMB 0.18
- Stochastic Oscillator
- NTIC 26.67
- INMB 83.61
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.